申请人:Schibli Roger
公开号:US10322195B2
公开(公告)日:2019-06-18
The present invention is directed towards new 18F-folate radiopharmaceuticals, wherein the 18F isotope F is linked via a prosthetic group, more specifically via a prosthetic group having a saccharide group, such as a cyclic mono- or oligosaccharide, preferably based on a pyranoside or furanoside, which is covalently linked to the glutamate portion of a folate or derivative thereof, a method of their preparation, as well as their use in diagnosis and monitoring of cancer and inflammatory and autoimmune diseases and therapy thereof.
本发明旨在开发新的 18F 叶酸放射性药物,其中 18F 同位素 F 通过人工基团连接,更具体地说,是通过具有糖基(如环状单糖或寡糖,最好是基于吡喃糖苷或呋喃糖苷)的人工基团连接,该人工基团与叶酸或其衍生物的谷氨酸部分共价连接,本发明还涉及其制备方法以及在癌症、炎症性和自身免疫性疾病的诊断和监测及其治疗中的用途。